Table 3 Number of infections (ICD-10 codes) and antimicrobial prescriptions (ATC-codes) among SMM individuals and MGUS individuals.
From: Increased risk of infections in smoldering multiple myeloma: results from the screened iStopMM study
SMM | MGUS | HR (95% CI) | ||
Total, N | 188 | 188 | Time-to-first infection | Recurrent infection |
All infections (ICD-10 codes), N | 179 | 168 | 1.37 (1.00–1.87) | 1.23 (0.93–1.63) |
Other infections, N | 43 | 47 | 1.14 (0.69–1.87) | 1.02 (0.63–1.65) |
Bacterial infections, N | 60 | 57 | 1.46 (0.92–2.33) | 1.23 (0.76–1.99) |
Viral infections, N | 53 | 49 | 1.31 (0.82–2.08) | 1.24 (0.80–1.90) |
Fungal infections, N | 23 | 15 | 0.95 (0.42–2.18) | 1.16 (0.34–3.98) |
All antimicrobials (ATC codes), N | 448 | 502 | 1.22 (0.94–1.59) | 1.01 (0.78–1.30) |
Antibacterial, N | 406 | 432 | 1.18 (0.91–1.54) | 1.95 (0.83–1.32) |
Antiviral, N | 13 | 36 | 1.54 (0.54–4.38) | 0.99 (0.35–2.78) |
Antifungal, N | 29 | 34 | 1.03 (0.55–1.94) | 0.93 (0.46–1.90) |
